ALK Positive and LUNGevity Foundation have issued a Request for Application for ALK-positive Lung Cancer Research Awards to be granted in 2022.
Letters of intent are due by Feb. 23, 2022. For those invited to submit a full application, the due date will be May 9, 2022.
Funded projects are expected to have a direct impact on the outcomes of patients with advanced ALK-positive lung cancer, but innovative proposals that address other unmet needs in the ALK-positive lung cancer space are also invited for submission.
The ALK-positive award has no geographical restrictions; international researchers may apply. The successful applicant may receive up to $750,000 over an award term of two years.
The Request for Applications is posted on the proposalCENTRAL website here. For more information, contact Margery Jacobson at mjacobson@LUNGevity.org.
